Innovative MulticOmponent Drug dEsign (MODE) for enhancing regional strategic advantages in pharmaceutical and biomedical applications

01 July 2016 → 30 June 2021
European funding: various
Research disciplines
  • Medical and health sciences
    • Pharmaceutical technology
Drug development
Project description

The overall objective is to enhance R&D on major societal challenges for improved healthcare by developing solutions for novel pharmaceutical products and

medical devices through new multicomponent drug systems. Our strategy will involve major stakeholders in the field including Universities, small and large

entreprises and final users (patients) as well as an economic development agency. Technology transfer and industrial competitiveness will be enhanced. Trainings

through technological develop. will create highly skilled scientists reducing the shortage of qualified staff in the field.